Vertex’s Cystic Fibrosis Sales Beat, as Newer Drugs Miss

Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay ...

Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% ...

The Best Stocks to Invest $50,000 In Right Now

Alphabet is also a major player in key emerging technologies. Its Waymo unit is the leader in the rapidly expanding robotaxi ...
STAT

A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk

Vertex Pharmaceuticals made history Friday when it received regulatory approval for a medicine that could alter people’s DNA. While the company celebrated, its founder, Joshua Boger, looked on like a ...
Nasdaq

If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today

Vertex Pharmaceuticals (NASDAQ: VRTX) has been one of the fastest-growing healthcare companies in recent years. Its products have made it a leader in cystic fibrosis (CF) treatment and it has been ...

Vertex’s cystic fibrosis sales beat expectations, as newer drugs miss

Boston-based Vertex reported revenue of $3.08 billion, an 11 percent gain from one year ago. That was ahead of analysts’ ...